Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization Churchill PharmaceuticalsStartup |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | US | Churchill PharmaceuticalsStartup | - |
Non-Small Cell Lung Cancer | Preclinical | AU | - | |
Pancreatic Cancer | Preclinical | AU | - | |
Pancreatic Cancer | Preclinical | US | Churchill PharmaceuticalsStartup | - |
Lung Cancer | Discovery | US | 30 Jan 2022 |